Clinical Trials Browser

Phase 1 × fedratinib × 1 year × Clear all

NCT05127174 2025-12-04

Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms

Phase 1 Terminated

Myeloproliferative Disorders